{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T01:32:10Z","timestamp":1788571930527,"version":"build-2803163510"},"reference-count":98,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,3,6]],"date-time":"2018-03-06T00:00:00Z","timestamp":1520294400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"crossref","award":["R01CA132931"],"award-info":[{"award-number":["R01CA132931"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1007\/s10549-018-4738-6","type":"journal-article","created":{"date-parts":[[2018,3,6]],"date-time":"2018-03-06T10:42:52Z","timestamp":1520332972000},"page":"55-67","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Exercise and weight loss interventions and miRNA expression in women with breast cancer"],"prefix":"10.1007","volume":"170","author":[{"given":"Brian D.","family":"Adams","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Arem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica J.","family":"Hubal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda","family":"Cartmel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangyong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maura","family":"Harrigan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara","family":"Sanft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lajos","family":"Pusztai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melinda L.","family":"Irwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,6]]},"reference":[{"key":"4738_CR1","first-page":"409","volume":"61","author":"C Desantis","year":"2011","unstructured":"Desantis C, Siegel R, Bandi P et al (2011) Breast cancer statistics, 2011. Cancer 61:409\u2013418","journal-title":"Cancer"},{"key":"4738_CR2","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1158\/1055-9965.EPI-08-1082","volume":"18","author":"CR Eheman","year":"2009","unstructured":"Eheman CR, Shaw KM, Ryerson AB et al (2009) The changing incidence of in situ and invasive ductal and lobular breast carcinomas: United States, 1999\u20132004. Cancer Epidemiol Biomarkers Prev 18:1763\u20131769","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"4738_CR3","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.canep.2012.02.007","volume":"36","author":"DR Youlden","year":"2012","unstructured":"Youlden DR, Cramb SM, Dunn NAM et al (2012) The descriptive epidemiology of female breast cancer: an international comparison of screening, incidence, survival and mortality. Cancer Epidemiol 36:237\u2013248","journal-title":"Cancer Epidemiol"},{"key":"4738_CR4","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1093\/jnci\/92.14.1126","volume":"92","author":"AM Martin","year":"2000","unstructured":"Martin AM, Weber BL (2000) Genetic and hormonal risk factors in breast cancer. J Natl Cancer Inst 92:1126\u20131135","journal-title":"J Natl Cancer Inst"},{"key":"4738_CR5","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/S0140-6736(05)67424-7","volume":"366","author":"HJ Cordell","year":"2005","unstructured":"Cordell HJ, Clayton DG (2005) Genetic association studies. Lancet 366:1121\u20131131","journal-title":"Lancet"},{"key":"4738_CR6","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/906495","author":"A Amadou","year":"2013","unstructured":"Amadou A, Hainaut P, Romieu I (2013) Role of obesity in the risk of breast cancer: Lessons from anthropometry J. Oncol. \n                    https:\/\/doi.org\/10.1155\/2013\/906495","journal-title":"Oncol"},{"key":"4738_CR7","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1097\/00008469-200102000-00003","volume":"10","author":"CM Friedenreich","year":"2001","unstructured":"Friedenreich CM (2001) Review of anthropometric factors and breast cancer risk. Eur J Cancer Prev 10:15\u201332","journal-title":"Eur J Cancer Prev"},{"key":"4738_CR8","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1146\/annurev.genom.9.081307.164339","volume":"9","author":"C Turnbull","year":"2008","unstructured":"Turnbull C, Rahman N (2008) Genetic predisposition to breast cancer: past, present, and future. Annu Rev Genomics Hum Genet 9:321\u2013345","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"4738_CR9","doi-asserted-by":"publisher","first-page":"e0126096","DOI":"10.1371\/journal.pone.0126096","volume":"10","author":"A Castello","year":"2015","unstructured":"Castello A, Martin M, Ruiz A et al (2015) Lower breast cancer risk among women following the world cancer research fund and american institute for cancer research lifestyle recommendations: EpiGEICAM case-control study. PLoS ONE 10:e0126096","journal-title":"PLoS ONE"},{"issue":"5","key":"4738_CR10","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1097\/CEJ.0000000000000406","volume":"26","author":"N Shapira","year":"2017","unstructured":"Shapira N (2017) The potential contribution of dietary factors to breast cancer prevention. Eur J Cancer Prev 26(5):385","journal-title":"Eur J Cancer Prev"},{"key":"4738_CR11","doi-asserted-by":"publisher","first-page":"2602","DOI":"10.1002\/ijc.29994","volume":"138","author":"SJO Nomura","year":"2016","unstructured":"Nomura SJO, Inoue-Choi M, Lazovich D et al (2016) WCRF\/AICR recommendation adherence and breast cancer incidence among postmenopausal women with and without non-modifiable risk factors. Int J Cancer 138:2602\u20132615","journal-title":"Int J Cancer"},{"key":"4738_CR12","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1158\/1055-9965.EPI-08-0595","volume":"18","author":"B Sternfeld","year":"2009","unstructured":"Sternfeld B, Weltzien E, Quesenberry CP et al (2009) Physical activity and risk of recurrence and mortality in breast cancer survivors: findings from the LACE study. Cancer Epidemiol Biomarkers Prev 18:87\u201395","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"4738_CR13","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1200\/JCO.2005.01.079","volume":"23","author":"CH Kroenke","year":"2005","unstructured":"Kroenke CH, Chen WY, Rosner B et al (2005) Weight, weight gain, and survival after breast cancer diagnosis. J Clin Oncol 23:1370\u20131378","journal-title":"J Clin Oncol"},{"key":"4738_CR14","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1001\/jamaoncol.2015.1546","volume":"1","author":"ML Neuhouser","year":"2015","unstructured":"Neuhouser ML, Aragaki AK, Prentice RL et al (2015) Overweight, obesity, and postmenopausal invasive breast cancer risk. JAMA Oncol 1:611","journal-title":"JAMA Oncol"},{"key":"4738_CR15","doi-asserted-by":"publisher","first-page":"3133","DOI":"10.1200\/JCO.2016.66.4391","volume":"34","author":"H Greenlee","year":"2016","unstructured":"Greenlee H, Shi Z, Sardo Molmenti CL et al (2016) Trends in obesity prevalence in adults with a history of cancer: results from the US national health interview survey, 1997 to 2014. J Clin Oncol 34:3133\u20133140","journal-title":"J Clin Oncol"},{"key":"4738_CR16","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1158\/1055-9965.EPI-12-0306","volume":"21","author":"BJ Caan","year":"2012","unstructured":"Caan BJ, Kwan ML, Shu XO et al (2012) Weight change and survival after breast cancer in the after breast cancer pooling project. Cancer Epidemiol Biomarkers Prev 21:1260\u20131271","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"4738_CR17","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1007\/s10549-009-0708-3","volume":"122","author":"X Chen","year":"2010","unstructured":"Chen X, Lu W, Zheng W et al (2010) Obesity and weight change in relation to breast cancer survival. Breast Cancer Res Treat 122:823\u2013833","journal-title":"Breast Cancer Res Treat"},{"key":"4738_CR18","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/291546","author":"G Pergola De","year":"2013","unstructured":"De Pergola G, Silvestris F (2013) Obesity as a major risk factor for cancer. J Obes. \n                    https:\/\/doi.org\/10.1155\/2013\/291546","journal-title":"J Obes"},{"key":"4738_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1207\/S15327914NC4501_1","volume":"45","author":"GD Stephenson","year":"2003","unstructured":"Stephenson GD, Rose DP (2003) Breast cancer and obesity: an update. Nutr Cancer 45:1\u201316","journal-title":"Nutr Cancer"},{"key":"4738_CR20","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1158\/0008-5472.CAN-12-3731","volume":"73","author":"C Baer","year":"2013","unstructured":"Baer C, Claus R, Plass C (2013) Genome-wide epigenetic regulation of miRNAs in cancer. Cancer Res 73:473\u2013477","journal-title":"Cancer Res"},{"key":"4738_CR21","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.cell.2005.06.036","volume":"122","author":"CM Croce","year":"2005","unstructured":"Croce CM, Calin GA (2005) miRNAs, cancer, and stem cell division. Cell 122:6\u20137","journal-title":"Cell"},{"key":"4738_CR22","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.2353\/ajpath.2009.080794","volume":"174","author":"R Visone","year":"2009","unstructured":"Visone R, Croce CM (2009) MiRNAs and Cancer. Am J Pathol 174:1131\u20131138","journal-title":"Am J Pathol"},{"key":"4738_CR23","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/B978-0-12-380866-0.60004-6","volume":"70","author":"M Fabbri","year":"2010","unstructured":"Fabbri M, Calin GA (2010) Epigenetics and miRNAs in Human Cancer. Adv Gene 70:87\u201399","journal-title":"Adv Gene"},{"key":"4738_CR24","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/nrc1840","volume":"6","author":"A Esquela-Kerscher","year":"2006","unstructured":"Esquela-Kerscher A, Slack FJ (2006) Oncomirs\u2014microRNAs with a role in cancer. Nat Rev Cancer 6:259\u2013269","journal-title":"Nat Rev Cancer"},{"issue":"16","key":"4738_CR25","doi-asserted-by":"publisher","first-page":"R762","DOI":"10.1016\/j.cub.2014.06.043","volume":"24","author":"BD Adams","year":"2014","unstructured":"Adams BD, Kasinski AL, Slack FJ (2014) Aberrant regulation and function of microRNAs in cancer. Curr Biol 24(16):R762\u2013R776","journal-title":"Curr Biol"},{"issue":"3","key":"4738_CR26","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1172\/JCI84424","volume":"127","author":"B Adams","year":"2017","unstructured":"Adams B, Parsons C, Walker L et al (2017) Targeting noncoding RNAs in disease. J Clin Investig 127(3):761\u2013771","journal-title":"J Clin Investig"},{"key":"4738_CR27","doi-asserted-by":"publisher","first-page":"5848","DOI":"10.1200\/JCO.2009.24.0317","volume":"27","author":"MV Iorio","year":"2009","unstructured":"Iorio MV, Croce CM (2009) MicroRNAs in cancer: small molecules with a huge impact. J Clin Oncol 27:5848\u20135856","journal-title":"J Clin Oncol"},{"key":"4738_CR28","doi-asserted-by":"publisher","first-page":"73","DOI":"10.2217\/14796694.2.1.73","volume":"2","author":"FJ Slack","year":"2006","unstructured":"Slack FJ, Weidhaas JB (2006) MicroRNAs as a potential magic bullet in cancer. Futur Oncol 2:73\u201382","journal-title":"Futur Oncol"},{"key":"4738_CR29","doi-asserted-by":"publisher","first-page":"S52","DOI":"10.1038\/onc.2009.353","volume":"27","author":"P Trang","year":"2009","unstructured":"Trang P, Weidhaas JB, Slack FJ (2009) MicroRNAs as potential cancer therapeutics. Oncogene 27:S52\u2013S57","journal-title":"Oncogene"},{"key":"4738_CR30","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13058-015-0526-y","volume":"17","author":"E Schooneveld van","year":"2015","unstructured":"van Schooneveld E, Wildiers H, Vergote I et al (2015) Dysregulation of microRNAs in breast cancer and their potential role as prognostic and predictive biomarkers in patient management. Breast Cancer Res 17:21","journal-title":"Breast Cancer Res"},{"key":"4738_CR31","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1517\/14728222.2016.1114102","volume":"20","author":"BD Adams","year":"2016","unstructured":"Adams BD, Parsons C, Slack FJ (2016) The tumor-suppressive and potential therapeutic functions of miR-34a in epithelial carcinomas. Expert Opin Ther Targets 20:737\u2013753","journal-title":"Expert Opin Ther Targets"},{"key":"4738_CR32","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.cmet.2006.01.005","volume":"3","author":"C Esau","year":"2006","unstructured":"Esau C, Davis S, Murray SF et al (2006) miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab 3:87\u201398","journal-title":"Cell Metab"},{"key":"4738_CR33","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.coph.2010.05.010","volume":"10","author":"HM Heneghan","year":"2010","unstructured":"Heneghan HM, Miller N, Kerin MJ (2010) MiRNAs as biomarkers and therapeutic targets in cancer. Curr Opin Pharmacol 10:543\u2013550","journal-title":"Curr Opin Pharmacol"},{"key":"4738_CR34","doi-asserted-by":"publisher","first-page":"304","DOI":"10.2174\/156652411795677990","volume":"11","author":"RA McGregor","year":"2011","unstructured":"McGregor RA, Choi MS (2011) microRNAs in the regulation of adipogenesis and obesity. Curr Mol Med 11:304\u2013316","journal-title":"Curr Mol Med"},{"key":"4738_CR35","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1200\/JCO.2014.57.1547","volume":"33","author":"ML Irwin","year":"2015","unstructured":"Irwin ML, Cartmel B, Gross CP et al (2015) Randomized exercise trial of aromatase inhibitor-induced arthralgia in breast cancer survivors. J Clin Oncol 33:1104\u20131111","journal-title":"J Clin Oncol"},{"key":"4738_CR36","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1200\/JCO.2015.61.6375","volume":"34","author":"M Harrigan","year":"2016","unstructured":"Harrigan M, Cartmel B, Loftfield E et al (2016) Randomized trial comparing telephone versus in-person weight loss counseling on body composition and circulating biomarkers in women treated for breast cancer: the lifestyle, exercise, and nutrition (LEAN) study. J Clin Oncol 34:669\u2013676","journal-title":"J Clin Oncol"},{"key":"4738_CR37","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1038\/oby.2009.18","volume":"17","author":"ML Irwin","year":"2009","unstructured":"Irwin ML, Alvarez-Reeves M, Cadmus L et al (2009) Exercise improves body fat, lean mass, and bone mass in breast cancer survivors. Obesity 17:1534\u20131541","journal-title":"Obesity"},{"key":"4738_CR38","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1056\/NEJMoa012512","volume":"346","author":"WC Knowler","year":"2002","unstructured":"Knowler WC, Barrett-Connor E, Fowler SE et al (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393\u2013403","journal-title":"N Engl J Med"},{"key":"4738_CR39","doi-asserted-by":"publisher","first-page":"243","DOI":"10.3322\/caac.21142","volume":"62","author":"CL Rock","year":"2012","unstructured":"Rock CL, Doyle C, Meyerhardt W et al (2012) Nutrition and Physical Activity Guidelines for Cancer Survivors. CA Cancer J Clin 62:243\u2013274","journal-title":"CA Cancer J Clin"},{"key":"4738_CR40","unstructured":"US Department of Health and Human Services and US Department of Agriculture (2015) Dietary guidelines for Americans, 2015\u20132020. vol 232, 8th edn p 71 \n                    http:\/\/health.gov\/dietaryguidelines\/2015\/guidelines\/"},{"key":"4738_CR41","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/S0002-8223(02)90064-7","volume":"102","author":"D Rogers","year":"2002","unstructured":"Rogers D, Leonberg BL, Broadhurst CB et al (2002) 2000 Commission on dietetic registration dietetics practice audit. J Am Diet Assoc 102:270\u2013292","journal-title":"J Am Diet Assoc"},{"key":"4738_CR42","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1016\/j.jand.2016.08.003","volume":"116","author":"K Griswold","year":"2016","unstructured":"Griswold K, Rogers D, Sauer KL et al (2016) Entry-level dietetics practice today: results from the 2015 commission on dietetic registration entry-level dietetics practice audit. J Acad Nutr Diet 116:1632\u20131684","journal-title":"J Acad Nutr Diet"},{"key":"4738_CR43","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1158\/1940-6207.CAPR-12-0278","volume":"6","author":"SB Jones","year":"2013","unstructured":"Jones SB, Thomas GA, Hesselsweet SD et al (2013) Effect of exercise on markers of inflammation in breast cancer survivors: the yale exercise and survivorship study. Cancer Prev Res 6:109\u2013118","journal-title":"Cancer Prev Res"},{"issue":"5817","key":"4738_CR44","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1126\/science.1134929","volume":"315","author":"DC Pregibon","year":"2007","unstructured":"Pregibon DC, Toner M, Doyle PS (2007) Multifunctional encoded particles for high-throughput biomolecule analysis. Science 315(5817):1393\u20131396","journal-title":"Science"},{"issue":"4","key":"4738_CR45","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1158\/0008-5472.CAN-15-2321","volume":"76","author":"BD Adams","year":"2015","unstructured":"Adams BD, Wali VB, Cheng CJ (2015) miR-34a Silences c-SRC to attenuate tumor growth in triple-negative breast cancer. Cancer Res 76(4):927\u2013939","journal-title":"Cancer Res"},{"key":"4738_CR46","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1002\/anie.201006523","volume":"50","author":"SC Chapin","year":"2011","unstructured":"Chapin SC, Appleyard DC, Pregibon DC et al (2011) Rapid microRNA profiling on encoded gel microparticles. Angew Chemie\u2014Int Ed 50:2289\u20132293","journal-title":"Angew Chemie\u2014Int Ed"},{"key":"4738_CR47","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/gb-2002-3-7-research0034","volume":"3","author":"J Vandesompele","year":"2002","unstructured":"Vandesompele J, De Preter K, Pattyn F et al (2002) Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3:34","journal-title":"Genome Biol"},{"issue":"4","key":"4738_CR48","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/onc.2016.222","volume":"36","author":"C Metheetrairut","year":"2016","unstructured":"Metheetrairut C, Adams BD (2016) Nallur Scel-mir-237 and its homologue, hsa-miR-125b, modulate the cellular response to ionizing radiation. Oncogene 36(4):512","journal-title":"Oncogene"},{"key":"4738_CR49","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1210\/me.2009-0062","volume":"23","author":"BD Adams","year":"2009","unstructured":"Adams BD, Cowee DM, White BA (2009) The Role of miR-206 in the epidermal growth factor (EGF) induced repression of estrogen receptor-\u03b1 (ER\u03b1) Signaling and a luminal Phenotype in MCF-7 Breast Cancer Cells. Mol Endocrinol 23:1215\u20131230","journal-title":"Mol Endocrinol"},{"issue":"6","key":"4738_CR50","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1055\/s-0028-1096132","volume":"26","author":"B Adams","year":"2008","unstructured":"Adams B, Guttilla I, White B (2008) Involvement of MicroRNAs in breast cancer. Semin Reprod Med 26(6):522\u2013536","journal-title":"Semin Reprod Med"},{"key":"4738_CR51","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1139\/bcb-2012-0053","volume":"91","author":"H Ling","year":"2013","unstructured":"Ling H, Li X, Yao CH et al (2013) The physiological and pathophysiological roles of adipocyte miRNAs. Biochem Cell Biol 91:195\u2013202","journal-title":"Biochem Cell Biol"},{"key":"4738_CR52","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.tem.2013.05.002","volume":"24","author":"M Trajkovski","year":"2013","unstructured":"Trajkovski M, Lodish H (2013) MicroRNA networks regulate development of brown adipocytes. Trends Endocrinol Metab 24:442\u2013450","journal-title":"Trends Endocrinol Metab"},{"key":"4738_CR53","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1002\/cbin.10063","volume":"37","author":"L Chen","year":"2013","unstructured":"Chen L, Song J, Cui J et al (2013) Micrornas regulate adipocyte differentiation. Cell Biol Int 37:533\u2013546","journal-title":"Cell Biol Int"},{"key":"4738_CR54","doi-asserted-by":"publisher","first-page":"105","DOI":"10.3945\/an.116.013839","volume":"8","author":"J Cui","year":"2017","unstructured":"Cui J, Zhou B, Ross SA et al (2017) Nutrition, microRNAs, and human health. Adv Nutr An Int Rev J 8:105\u2013112","journal-title":"Adv Nutr An Int Rev J"},{"key":"4738_CR55","doi-asserted-by":"publisher","first-page":"885","DOI":"10.5114\/aoms.2017.65229","volume":"13","author":"A Sliwinska","year":"2017","unstructured":"Sliwinska A, Kasinska MA, Drzewoski J (2017) MicroRNAs & metabolic disorders\u2014where are we heading? Arch Med Sci 13:885\u2013896","journal-title":"Arch Med Sci"},{"key":"4738_CR56","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/6754734","author":"C Nardelli","year":"2017","unstructured":"Nardelli C, Iaffaldano L, Pilone V (2017) Changes in the MicroRNA profile observed in the subcutaneous adipose tissue of obese patients after laparoscopic adjustable gastric banding. J Obes. \n                    https:\/\/doi.org\/10.1155\/2017\/6754734","journal-title":"J Obes"},{"key":"4738_CR57","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1373\/clinchem.2012.195776","volume":"59","author":"FJ Ortega","year":"2013","unstructured":"Ortega FJ, Mercader JM, Catal\u00e1n V et al (2013) Targeting the circulating microRNA signature of obesity. Clin Chem 59:781\u2013792","journal-title":"Clin Chem"},{"key":"4738_CR58","doi-asserted-by":"publisher","first-page":"R214","DOI":"10.1186\/gb-2007-8-10-r214","volume":"8","author":"C Blenkiron","year":"2007","unstructured":"Blenkiron C, Goldstein LD, Thorne NP et al (2007) MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype. Genome Biol 8:R214","journal-title":"Genome Biol"},{"key":"4738_CR59","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.4161\/rna.21619","volume":"9","author":"KW Witwer","year":"2012","unstructured":"Witwer KW (2012) XenomiRs and miRNA homeostasis in health and disease: evidence that diet and dietary miRNAs directly and indirectly influence circulating miRNA profiles. RNA Biol 9:1147\u20131154","journal-title":"RNA Biol"},{"key":"4738_CR60","unstructured":"SAS Institute Inc (2014) SAS software 9.4. SAS Inst Inc Mark Co pp 1\u201325"},{"key":"4738_CR61","doi-asserted-by":"publisher","first-page":"D163","DOI":"10.1093\/nar\/gkq1107","volume":"39","author":"H Da","year":"2011","unstructured":"Da H, Lin FM, Wu WY (2011) MiRTarBase: a database curates experimentally validated microRNA-target interactions. Nucleic Acids Res 39:D163\u2013D169","journal-title":"Nucleic Acids Res"},{"key":"4738_CR62","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","volume":"136","author":"DP Bartel","year":"2009","unstructured":"Bartel DP (2009) MicroRNAs: target recognition and regulatory functions. Cell 136:215\u2013233","journal-title":"Cell"},{"key":"4738_CR63","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/ncb3094","volume":"17","author":"MY Fong","year":"2015","unstructured":"Fong MY, Zhou W, Liu L et al (2015) Breast-cancer-secreted miR-122 reprograms glucose\u00a0metabolism in premetastatic niche to\u00a0promote\u00a0metastasis. Nat Cell Biol 17:183\u2013194","journal-title":"Nat Cell Biol"},{"key":"4738_CR64","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1038\/nm.3309","volume":"19","author":"C Pola","year":"2013","unstructured":"Pola C (2013) Cancer: miR-22 attacks on several fronts. Nat Med 19:980","journal-title":"Nat Med"},{"key":"4738_CR65","doi-asserted-by":"publisher","first-page":"2766","DOI":"10.1038\/onc.2015.333","volume":"35","author":"C Koufaris","year":"2016","unstructured":"Koufaris C, Valbuena GN, Pomyen Y et al (2016) Systematic integration of molecular profiles identifies miR-22 as a regulator of lipid and folate metabolism in breast cancer cells. Oncogene 35:2766\u20132776","journal-title":"Oncogene"},{"key":"4738_CR66","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s10549-014-3040-5","volume":"146","author":"M Fan","year":"2014","unstructured":"Fan M, Sethuraman A, Brown M et al (2014) Systematic analysis of metastasis-associated genes identifies miR-17-5p as a metastatic suppressor of basal-like breast cancer. Breast Cancer Res Treat 146:487\u2013502","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"4738_CR67","doi-asserted-by":"publisher","first-page":"e1003311","DOI":"10.1371\/journal.pgen.1003311","volume":"9","author":"G Leva Di","year":"2013","unstructured":"Di Leva G, Piovan C, Gasparini P (2013) Estrogen mediated-activation of miR-191\/425 cluster modulates tumorigenicity of breast cancer cells depending on estrogen receptor Status. PLoS genet 9(3):e1003311","journal-title":"PLoS genet"},{"key":"4738_CR68","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.jss.2014.12.035","volume":"195","author":"R Zheng","year":"2015","unstructured":"Zheng R, Pan L, Gao J et al (2015) Prognostic value of miR-106b expression in breast cancer patients. J Surg Res 195:158\u2013165","journal-title":"J Surg Res"},{"key":"4738_CR69","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1128\/MCB.01977-07","volume":"28","author":"I Ivanovska","year":"2008","unstructured":"Ivanovska I, Ball AS, Diaz RL et al (2008) MicroRNAs in the miR-106b family regulate p21\/CDKN1A and promote cell cycle progression. Mol Cell Biol 28:2167\u20132174","journal-title":"Mol Cell Biol"},{"key":"4738_CR70","first-page":"14619","volume":"8","author":"CY Wei","year":"2015","unstructured":"Wei CY, Tan QX, Zhu X et al (2015) Expression of CDKN1A\/p21 and TGFBR2 in breast cancer and their prognostic significance. Int J Clin Exp Pathol 8:14619\u201314629","journal-title":"Int J Clin Exp Pathol"},{"key":"4738_CR71","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/sj.bjc.6600109","volume":"86","author":"I Bi\u00e8che","year":"2002","unstructured":"Bi\u00e8che I, Olivi M, Nogu\u00e8s C et al (2002) Prognostic value of CCND1 gene status in sporadic breast tumours, as determined by real-time quantitative PCR assays. Br J Cancer 86:580\u2013586","journal-title":"Br J Cancer"},{"issue":"1","key":"4738_CR72","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.maturitas.2004.06.005","volume":"49","author":"P Kenemans","year":"2004","unstructured":"Kenemans P, Verstraeten RA, Verheijen RHM (2004) Oncogenic pathways in hereditary and sporadic breast cancer. Maturitas 49(1):34\u201343","journal-title":"Maturitas"},{"key":"4738_CR73","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1111\/j.1600-0404.2008.01102.x","volume":"119","author":"O Stich","year":"2009","unstructured":"Stich O, Rasiah C, Rauer S (2009) Paraneoplastic antibody during follow-up of a patient with anti-Ri-associated paraneoplastic neurological syndrome. Acta Neurol Scand 119:338\u2013340","journal-title":"Acta Neurol Scand"},{"key":"4738_CR74","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12929-016-0288-6","volume":"23","author":"YA Zhang","year":"2016","unstructured":"Zhang YA, Liu HN, Zhu JM et al (2016) RNA binding protein Nova1 promotes tumor growth in vivo and its potential mechanism as an oncogene may due to its interaction with GABAA Receptor-gamma2. J Biomed Sci 23:71","journal-title":"J Biomed Sci"},{"key":"4738_CR75","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/nature09783","volume":"469","author":"EM Small","year":"2011","unstructured":"Small EM, Olson EN (2011) Pervasive roles of microRNAs in cardiovascular biology. Nature 469:336\u2013342","journal-title":"Nature"},{"key":"4738_CR76","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/S0092-8674(00)81359-8","volume":"87","author":"BM Spiegelman","year":"1996","unstructured":"Spiegelman BM, Flier JS (1996) Adipogenesis and obesity: rounding out the big picture. Cell 87:377\u2013389","journal-title":"Cell"},{"key":"4738_CR77","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.cmet.2016.05.012","volume":"24","author":"E Jeffery","year":"2016","unstructured":"Jeffery E, Wing A, Holtrup B et al (2016) The adipose tissue microenvironment regulates depot-specific adipogenesis in obesity. Cell Metab 24:142\u2013150","journal-title":"Cell Metab"},{"key":"4738_CR78","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/cphy.c160022","volume":"7","author":"PM s\u00e1 de","year":"2017","unstructured":"de s\u00e1 PM, Richard AJ, Hang H et al (2017) Transcriptional regulation of adipogenesis. Compr Physiol 7:635\u2013674","journal-title":"Compr Physiol"},{"key":"4738_CR79","doi-asserted-by":"publisher","first-page":"2362","DOI":"10.1172\/JCI32239","volume":"117","author":"Y Cao","year":"2007","unstructured":"Cao Y (2007) Angiogenesis modulates adipogenesis and obesity. J Clin Invest 117:2362\u20132368","journal-title":"J Clin Invest"},{"key":"4738_CR80","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/35013000","volume":"405","author":"S Kersten","year":"2000","unstructured":"Kersten S, Desvergne B, Wahli W (2000) Roles of PPARs in health and disease. Nature 405:421\u2013424","journal-title":"Nature"},{"key":"4738_CR81","doi-asserted-by":"publisher","DOI":"10.1155\/2008\/102737","author":"K Tachibana","year":"2008","unstructured":"Tachibana K, Yamasaki D, Ishimoto K (2008) The role of PPARs in cancer. PPAR Res. \n                    https:\/\/doi.org\/10.1155\/2008\/102737","journal-title":"PPAR Res"},{"issue":"3","key":"4738_CR82","doi-asserted-by":"publisher","first-page":"R195","DOI":"10.1530\/ERC-13-0512","volume":"21","author":"SA Dabydeen","year":"2014","unstructured":"Dabydeen SA, Furth PA (2014) Genetically engineered ER\u03b1-positive breast cancer mouse models. Endocr Relat Cancer 21(3):R195\u2013R208","journal-title":"Endocr Relat Cancer"},{"key":"4738_CR83","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1158\/1535-7163.MCT-13-0836","volume":"13","author":"PL Yao","year":"2014","unstructured":"Yao PL, Morales JL, Zhu B et al (2014) Activation of peroxisome proliferator-activated receptor-\u03b2\/\u03b4 (PPAR-\u03b2\/\u03b4) inhibits human breast cancer cell line tumorigenicity. Mol Cancer Ther 13:1008\u20131017","journal-title":"Mol Cancer Ther"},{"key":"4738_CR84","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1023\/A:1012230115173","volume":"69","author":"GH Ho","year":"2001","unstructured":"Ho GH, Calvano JE, Bisogna M et al (2001) Expression of E2F-1 and E2F-4 is reduced in primary and metastatic breast carcinomas*. Breast Cancer Res Treat 69:115\u2013122","journal-title":"Breast Cancer Res Treat"},{"key":"4738_CR85","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.tibs.2004.06.006","volume":"29","author":"AP Bracken","year":"2004","unstructured":"Bracken AP, Ciro M, Cocito A et al (2004) E2F target genes: unraveling the biology. Trends Biochem Sci 29:409\u2013417","journal-title":"Trends Biochem Sci"},{"key":"4738_CR86","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3389\/fgene.2015.00161","volume":"6","author":"LM Julian","year":"2015","unstructured":"Julian LM, Blais A (2015) Transcriptional control of stem cell fate by E2Fs and pocket proteins. Front Genet 6:161","journal-title":"Front Genet"},{"key":"4738_CR87","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/emboj.2012.306","volume":"32","author":"L Wang","year":"2012","unstructured":"Wang L, Xu S, Lee JE et al (2012) Histone H3K9 methyltransferase G9a represses PPAR\u03b3 expression and adipogenesis. EMBO J 32:45\u201359","journal-title":"EMBO J"},{"key":"4738_CR88","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/7058424","author":"D Portius","year":"2017","unstructured":"Portius D, Sobolewski C, Foti M (2017) MicroRNAs-dependent regulation of PPARs in metabolic diseases and cancers. PPAR Res. \n                    https:\/\/doi.org\/10.1155\/2017\/7058424","journal-title":"PPAR Res"},{"key":"4738_CR89","doi-asserted-by":"publisher","first-page":"268","DOI":"10.4161\/epi.27015","volume":"9","author":"KC Johnson","year":"2014","unstructured":"Johnson KC, Koestler DC, Cheng C et al (2014) Age-related DNA methylation in normal breast tissue and its relationship with invasive breast tumor methylation. Epigenetics 9:268\u2013275","journal-title":"Epigenetics"},{"key":"4738_CR90","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/S0092-8674(03)00401-X","volume":"113","author":"M Narita","year":"2003","unstructured":"Narita M, N\u0169nez S, Heard E et al (2003) Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell 113:703\u2013716","journal-title":"Cell"},{"key":"4738_CR91","doi-asserted-by":"publisher","first-page":"2555","DOI":"10.4161\/cc.9.13.12061","volume":"9","author":"S Emmrich","year":"2010","unstructured":"Emmrich S, P\u00fctzer BM (2010) Checks and balances: E2F-microRNA crosstalk in cancer control. Cell Cycle 9:2555\u20132567","journal-title":"Cell Cycle"},{"key":"4738_CR92","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1101\/gad.1781009","volume":"23","author":"D Gatfield","year":"2009","unstructured":"Gatfield D, Le Martelot G, Vejnar CE et al (2009) Integration of microRNA miR-122 in hepatic circadian gene expression. Genes Dev 23:1313\u20131326","journal-title":"Genes Dev"},{"key":"4738_CR93","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1111\/j.1440-1746.2009.05949.x","volume":"25","author":"L Zheng","year":"2010","unstructured":"Zheng L, Lv G, Sheng J et al (2010) Effect of miRNA-10b in regulating cellular steatosis level by targeting PPAR-\u00ce\u2009\u00b1\u2009expression, a novel mechanism for the pathogenesis of NAFLD. J Gastroenterol Hepatol 25:156\u2013163","journal-title":"J Gastroenterol Hepatol"},{"key":"4738_CR94","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.tem.2013.03.002","volume":"24","author":"M Hatziapostolou","year":"2013","unstructured":"Hatziapostolou M, Polytarchou C, Iliopoulos D (2013) MiRNAs link metabolic reprogramming to oncogenesis. Trends Endocrinol Metab 24:361\u2013373","journal-title":"Trends Endocrinol Metab"},{"key":"4738_CR95","doi-asserted-by":"publisher","first-page":"19678","DOI":"10.1073\/pnas.0811166106","volume":"105","author":"BD Aguda","year":"2008","unstructured":"Aguda BD, Kim Y, Piper-Hunter MG et al (2008) MicroRNA regulation of a cancer network: consequences of the feedback loops involving miR-17-92, E2F, and Myc. Proc Natl Acad Sci 105:19678\u201319683","journal-title":"Proc Natl Acad Sci"},{"key":"4738_CR96","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.cell.2013.03.043","volume":"153","author":"A Helwak","year":"2013","unstructured":"Helwak A, Kudla G, Dudnakova T et al (2013) Mapping the human miRNA interactome by CLASH reveals frequent noncanonical binding. Cell 153:654\u2013665","journal-title":"Cell"},{"key":"4738_CR97","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3389\/fgene.2014.00099","volume":"5","author":"N Nagpal","year":"2014","unstructured":"Nagpal N, Kulshreshtha R (2014) miR-191: An emerging player in disease biology. Front Genet 5:99","journal-title":"Front Genet"},{"issue":"1","key":"4738_CR98","doi-asserted-by":"publisher","first-page":"e54319","DOI":"10.1371\/journal.pone.0054319","volume":"8","author":"FI Milagro","year":"2013","unstructured":"Milagro FI, Miranda J, Portillo MP (2013) High-throughput sequencing of microRNAs in peripheral blood mononuclear Cells: identification of potential weight loss biomarkers. PLoS One 8(1):e54319","journal-title":"PLoS One"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-018-4738-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-018-4738-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-018-4738-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,5]],"date-time":"2019-03-05T21:29:56Z","timestamp":1551821396000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-018-4738-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,6]]},"references-count":98,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["4738"],"URL":"https:\/\/doi.org\/10.1007\/s10549-018-4738-6","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,6]]},"assertion":[{"value":"3 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"B.D. Adams is President and CEO\u00a0of The Brain Institute of America and holds patent interests with AUM LifeTech. Other authors have declared no conflicts of interest exist.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"This study analyzed data obtained from clinical trials Hormones and Physical Exercise (HOPE) Study; NCT02056067,  and Lifestyle, Exercise and Nutrition (LEAN)\u00a0Study; NCT02109068, .","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial"}}]}}